{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:40:27Z","timestamp":1777506027697,"version":"3.51.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T00:00:00Z","timestamp":1422316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s11892-014-0570-5","type":"journal-article","created":{"date-parts":[[2015,1,26]],"date-time":"2015-01-26T07:22:41Z","timestamp":1422256961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Using Oral Agents to Manage Gestational Diabetes: What Have We Learned?"],"prefix":"10.1007","volume":"15","author":[{"given":"Elizabeth","family":"Buschur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Wyckoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,27]]},"reference":[{"key":"570_CR1","unstructured":"6\/29\/2014; Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/017498s031lbl.pdf ."},{"key":"570_CR2","unstructured":"7\/5\/2014; Available from: http:\/\/packageinserts.bms.com\/pi\/pi_glucophage_xr.pdf ."},{"issue":"16","key":"570_CR3","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJM200010193431601","volume":"343","author":"O Langer","year":"2000","unstructured":"Langer O et al. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med. 2000;343(16):1134\u20138.","journal-title":"N Engl J Med"},{"issue":"6","key":"570_CR4","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/AOG.0000000000000285","volume":"123","author":"W Camelo Castillo","year":"2014","unstructured":"Camelo Castillo W et al. Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000\u20132011. Obstet Gynecol. 2014;123(6):1177\u201384. doi: 10.1097\/AOG.0000000000000285 .","journal-title":"Obstet Gynecol"},{"issue":"8","key":"570_CR5","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1464-5491.2011.03326.x","volume":"28","author":"DA Ogunyemi","year":"2011","unstructured":"Ogunyemi DA et al. Attitudes and practices of healthcare providers regarding gestational diabetes: results of a survey conducted at the 2010 meeting of the International Association of Diabetes in Pregnancy Study Group (IADPSG). Diabet Med. 2011;28(8):976\u201386.","journal-title":"Diabet Med"},{"key":"570_CR6","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780199541362.001.0001","volume-title":"Diabetes: the biography","author":"R Tattersall","year":"2009","unstructured":"Tattersall R. Diabetes: the biography. Oxford: Oxford University Press; 2009."},{"issue":"5373","key":"570_CR7","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1136\/bmj.2.5373.1652-c","volume":"2","author":"WP Jackson","year":"1963","unstructured":"Jackson WP, Campbell GD. Chlorpropamide and perinatal mortality. Br Med J. 1963;2(5373):1652.","journal-title":"Br Med J"},{"issue":"5402","key":"570_CR8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/bmj.2.5402.187","volume":"2","author":"JM Malins","year":"1964","unstructured":"Malins JM et al. Sulphonylurea drugs in pregnancy. Br Med J. 1964;2(5402):187.","journal-title":"Br Med J"},{"issue":"1","key":"570_CR9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2337\/diab.16.1.60","volume":"16","author":"CP Douglas","year":"1967","unstructured":"Douglas CP, Richards R. Use of chlorpropamide in the treatment of diabetes in pregnancy. Diabetes. 1967;16(1):60\u20131.","journal-title":"Diabetes"},{"issue":"9","key":"570_CR10","first-page":"226","volume":"45","author":"M Notelovitz","year":"1971","unstructured":"Notelovitz M. Sulphonylurea therapy in the treatment of the pregnant diabetic. S Afr Med J. 1971;45(9):226\u20139.","journal-title":"S Afr Med J"},{"issue":"4","key":"570_CR11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/adc.49.4.283","volume":"49","author":"HW Sutherland","year":"1974","unstructured":"Sutherland HW et al. Effect of moderate dosage of chlorpropamide in pregnancy on fetal outcome. Arch Dis Child. 1974;49(4):283\u201391.","journal-title":"Arch Dis Child"},{"issue":"5870","key":"570_CR12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/bmj.3.5870.9","volume":"3","author":"HW Sutherland","year":"1973","unstructured":"Sutherland HW et al. Evaluation of chlorpropamide in chemical diabetes diagnosed during pregnancy. Br Med J. 1973;3(5870):9\u201313.","journal-title":"Br Med J"},{"issue":"243","key":"570_CR13","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/adc.45.243.696","volume":"45","author":"ML Kemball","year":"1970","unstructured":"Kemball ML et al. Neonatal hypoglycaemia in infants of diabetic mothers given sulphonylurea drugs in pregnancy. Arch Dis Child. 1970;45(243):696\u2013701.","journal-title":"Arch Dis Child"},{"issue":"5","key":"570_CR14","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1542\/peds.42.5.824","volume":"42","author":"P Zucker","year":"1968","unstructured":"Zucker P, Simon G. Prolonged symptomatic neonatal hypoglycemia associated with maternal chlorpropamide therapy. Pediatrics. 1968;42(5):824\u20135.","journal-title":"Pediatrics"},{"issue":"4","key":"570_CR15","first-page":"368","volume":"128","author":"JD Uhrig","year":"1983","unstructured":"Uhrig JD, Hurley RM. Chlorpropamide in pregnancy and transient neonatal diabetes insipidus. Can Med Assoc J. 1983;128(4):368. 370\u20131.","journal-title":"Can Med Assoc J"},{"issue":"6","key":"570_CR16","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1530\/eje.0.1380698","volume":"138","author":"H Christesen","year":"1998","unstructured":"Christesen H, Melander A. Prolonged elimination of tolbutamide in a premature newborn with hyperinsulinaemic hypoglycaemia. Eur J Endocrinol. 1998;138(6):698\u2013701.","journal-title":"Eur J Endocrinol"},{"key":"570_CR17","unstructured":"7\/5\/14; Available from: http:\/\/en.wikipedia.org\/wiki\/Metformin#History ."},{"issue":"5","key":"570_CR18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/sj.jp.7211683","volume":"27","author":"GA Ramos","year":"2007","unstructured":"Ramos GA et al. Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia. J Perinatol. 2007;27(5):262\u20137.","journal-title":"J Perinatol"},{"issue":"5","key":"570_CR19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0168-8227(86)80036-5","volume":"1","author":"EJ Coetzee","year":"1985","unstructured":"Coetzee EJ, Jackson WPU. The management of non-insulin-dependent diabetes during pregnancy. Diabetes Res Clin Pract. 1985;1(5):281\u20137.","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"570_CR20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1464-5491.2000.00314.x","volume":"17","author":"E Hellmuth","year":"2000","unstructured":"Hellmuth E, Damm P, Molsted-Pedersen L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabet Med. 2000;17(7):507\u201311.","journal-title":"Diabet Med"},{"issue":"4 Pt 1","key":"570_CR21","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0002-9378(91)90421-M","volume":"165","author":"BD Elliott","year":"1991","unstructured":"Elliott BD et al. Insignificant transfer of glyburide occurs across the human placenta. Am J Obstet Gynecol. 1991;165(4 Pt 1):807\u201312.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"570_CR22","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0002-9378(94)90078-7","volume":"171","author":"BD Elliott","year":"1994","unstructured":"Elliott BD et al. Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer. Am J Obstet Gynecol. 1994;171(3):653\u201360.","journal-title":"Am J Obstet Gynecol"},{"issue":"11\u201312","key":"570_CR23","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.placenta.2005.11.012","volume":"27","author":"C Gedeon","year":"2006","unstructured":"Gedeon C et al. Transport of glyburide by placental ABC transporters: implications in fetal drug exposure. Placenta. 2006;27(11\u201312):1096\u2013102.","journal-title":"Placenta"},{"issue":"3","key":"570_CR24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/14767050801929901","volume":"21","author":"TN Nanovskaya","year":"2008","unstructured":"Nanovskaya TN et al. Effect of albumin on transplacental transfer and distribution of rosiglitazone and glyburide. J Matern Fetal Neonatal Med. 2008;21(3):197\u2013207.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"570_CR25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0890-6238(01)00122-8","volume":"15","author":"G Koren","year":"2001","unstructured":"Koren G. Glyburide and fetal safety; transplacental pharmacokinetic considerations. Reprod Toxicol. 2001;15(3):227\u20139.","journal-title":"Reprod Toxicol"},{"issue":"12","key":"570_CR26","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.bcp.2009.08.003","volume":"78","author":"OL Zharikova","year":"2009","unstructured":"Zharikova OL et al. Identification of the major human hepatic and placental enzymes responsible for the biotransformation of glyburide. Biochem Pharmacol. 2009;78(12):1483\u201390.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"570_CR27","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/bcp.12207","volume":"77","author":"AB Ke","year":"2014","unstructured":"Ke AB et al. Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19. Br J Clin Pharmacol. 2014;77(3):554\u201370.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"570_CR28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ajog.2005.12.005","volume":"195","author":"J Kraemer","year":"2006","unstructured":"Kraemer J et al. Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety. Am J Obstet Gynecol. 2006;195(1):270\u20134.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"570_CR29","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1124\/dmd.109.030791","volume":"38","author":"EK Pollex","year":"2010","unstructured":"Pollex EK et al. Breast cancer resistance protein (BCRP)-mediated glyburide transport: effect of the C421A\/Q141K BCRP single-nucleotide polymorphism. Drug Metab Dispos. 2010;38(5):740\u20134.","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"570_CR30","doi-asserted-by":"crossref","first-page":"383.e1","DOI":"10.1016\/j.ajog.2010.01.035","volume":"202","author":"SJ Hemauer","year":"2010","unstructured":"Hemauer SJ et al. Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin. Am J Obstet Gynecol. 2010;202(4):383.e1\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"570_CR31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.placenta.2012.01.008","volume":"33","author":"M Iqbal","year":"2012","unstructured":"Iqbal M et al. Placental drug transporters and their role in fetal protection. Placenta. 2012;33(3):137\u201342.","journal-title":"Placenta"},{"issue":"6","key":"570_CR32","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/clpt.2009.5","volume":"85","author":"MF Hebert","year":"2009","unstructured":"Hebert MF et al. Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther. 2009;85(6):607\u201314.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"570_CR33","first-page":"377","volume":"52","author":"JM Lim","year":"1997","unstructured":"Lim JM et al. A comparison between the pregnancy outcome of women with gestation diabetes treated with glibenclamide and those treated with insulin. Med J Malays. 1997;52(4):377\u201381.","journal-title":"Med J Malays"},{"issue":"5","key":"570_CR34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.jp.7210759","volume":"22","author":"L Goetzl","year":"2002","unstructured":"Goetzl L, Wilkins I. Glyburide compared to insulin for the treatment of gestational diabetes mellitus: a cost analysis. J Perinatol. 2002;22(5):403\u20136.","journal-title":"J Perinatol"},{"issue":"1","key":"570_CR35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ajog.2005.03.018","volume":"193","author":"GF Jacobson","year":"2005","unstructured":"Jacobson GF et al. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol. 2005;193(1):118\u201324.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"570_CR36","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.ajog.2006.07.029","volume":"195","author":"M Rochon","year":"2006","unstructured":"Rochon M et al. Glyburide for the management of gestational diabetes: risk factors predictive of failure and associated pregnancy outcomes. Am J Obstet Gynecol. 2006;195(4):1090\u20134.","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"570_CR37","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1463-1326.2007.00828.x","volume":"10","author":"RIG Holt","year":"2008","unstructured":"Holt RIG et al. The effectiveness of glibenclamide in women with gestational diabetes. Diabetes Obes Metab. 2008;10(10):906\u201311.","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"570_CR38","doi-asserted-by":"crossref","first-page":"476","DOI":"10.4103\/0019-5359.109534","volume":"65","author":"JE Mathews","year":"2011","unstructured":"Mathews JE et al. Retrospective cohort study comparing neonatal outcomes of women treated with glyburide or insulin in gestational diabetes: a 5-year experience in a South Indian teaching hospital. Indian J Med Sci. 2011;65(11):476\u201381.","journal-title":"Indian J Med Sci"},{"issue":"6","key":"570_CR39","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3109\/14767058.2010.531323","volume":"24","author":"Y Yogev","year":"2011","unstructured":"Yogev Y et al. Glyburide in gestational diabetes\u2014prediction of treatment failure. J Matern Fetal Neonatal Med. 2011;24(6):842\u20136.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"10","key":"570_CR40","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/sj.jp.7211147","volume":"24","author":"R Chmait","year":"2004","unstructured":"Chmait R, Dinise T, Moore T. Prospective observational study to establish predictors of glyburide success in women with gestational diabetes mellitus. J Perinatol. 2004;24(10):617\u201322.","journal-title":"J Perinatol"},{"key":"570_CR41","doi-asserted-by":"crossref","unstructured":"Bertini Anna, M., et al., Perinatal outcomes and the use of oral hypoglycemic agents, in Journal of Perinatal Medicine. 2005. p. 519.","DOI":"10.1515\/JPM.2005.092"},{"key":"570_CR42","doi-asserted-by":"crossref","unstructured":"Cheng YW et al. Treatment of gestational diabetes mellitus: glyburide compared to subcutaneous insulin therapy and associated perinatal outcomes. J Matern Fetal Neonatal Med. 2012;25(4):379\u201384. This is a large retrospective study of glyburide use in GDM. It is useful as it illustrates the outcomes of the real life application of glyburide in GDM.","DOI":"10.3109\/14767058.2011.580402"},{"issue":"1","key":"570_CR43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ajog.2004.07.011","volume":"192","author":"O Langer","year":"2005","unstructured":"Langer O et al. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome. Am J Obstet Gynecol. 2005;192(1):134\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"570_CR44","doi-asserted-by":"crossref","first-page":"501.e1","DOI":"10.1016\/j.ajog.2009.02.038","volume":"200","author":"KY Lain","year":"2009","unstructured":"Lain KY et al. Neonatal adiposity following maternal treatment of gestational diabetes with glyburide compared with insulin. Am J Obstet Gynecol. 2009;200(5):501.e1\u20136.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"570_CR45","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/jog.12042","volume":"39","author":"A Tempe","year":"2013","unstructured":"Tempe A, Mayanglambam RD. Glyburide as treatment option for gestational diabetes mellitus. J Obstet Gynaecol Res. 2013;39(6):1147\u201352.","journal-title":"J Obstet Gynaecol Res"},{"issue":"3","key":"570_CR46","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.diabres.2006.09.031","volume":"76","author":"C Anjalakshi","year":"2007","unstructured":"Anjalakshi C et al. A prospective study comparing insulin and glibenclamide in gestational diabetes mellitus in Asian Indian women. Diabetes Res Clin Pract. 2007;76(3):474\u20135.","journal-title":"Diabetes Res Clin Pract"},{"key":"570_CR47","doi-asserted-by":"crossref","unstructured":"Zeng Y-c et al. The use of glyburide in the management of gestational diabetes mellitus: a meta-analysis. Adv Med Sci. 2014;59(1):95\u2013101. This is a meta-analysis of RCTs of glyburide versus insulin. Most RCTs on this topic are under-powered to detect differences in neonatal outcomes, hence, the importance of a meta-analysis of the topic.","DOI":"10.1016\/j.advms.2014.03.001"},{"issue":"6\u20137","key":"570_CR48","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.placenta.2005.05.012","volume":"27","author":"M Wareing","year":"2006","unstructured":"Wareing M et al. Glibenclamide inhibits agonist-induced vasoconstriction of placental chorionic plate arteries. Placenta. 2006;27(6\u20137):660\u20138.","journal-title":"Placenta"},{"issue":"1","key":"570_CR49","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1464-5491.1992.tb01710.x","volume":"9","author":"RG Petty","year":"1992","unstructured":"Petty RG, Pearson JD. The influence of hypoglycaemic agents on the growth and metabolism of human endothelial cells. Diabet Med. 1992;9(1):30\u20137.","journal-title":"Diabet Med"},{"issue":"1","key":"570_CR50","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1476-5381.1991.tb12387.x","volume":"104","author":"SJ Downing","year":"1991","unstructured":"Downing SJ, Hollingsworth M. Antagonism of relaxin by glibenclamide in the uterus of the rat in vivo. Br J Pharmacol. 1991;104(1):71\u20136.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"570_CR51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11892-011-0249-0","volume":"12","author":"J Ballas","year":"2012","unstructured":"Ballas J, Moore TR, Ramos GA. Management of diabetes in pregnancy. Curr Diabetes Rep. 2012;12(1):33\u201342.","journal-title":"Curr Diabetes Rep"},{"issue":"1","key":"570_CR52","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bpobgyn.2010.10.018","volume":"25","author":"W Nicholson","year":"2011","unstructured":"Nicholson W, Baptiste-Roberts K. Oral hypoglycaemic agents during pregnancy: the evidence for effectiveness and safety. Best Prac Res Clin Obstet Gynaecol. 2011;25(1):51\u201363.","journal-title":"Best Prac Res Clin Obstet Gynaecol"},{"key":"570_CR53","doi-asserted-by":"crossref","unstructured":"Cassina, M., et al., First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis. Human Reproduction Update, 2014.","DOI":"10.1093\/humupd\/dmu022"},{"issue":"Suppl 2","key":"570_CR54","doi-asserted-by":"crossref","first-page":"S214","DOI":"10.2337\/dc07-s219","volume":"30","author":"JA Rowan","year":"2007","unstructured":"Rowan JA, Mi GI. A trial in progress: gestational diabetes. Treatment with metformin compared with insulin (the Metformin in Gestational Diabetes [MiG] trial). Diabetes Care. 2007;30 Suppl 2:S214\u20139.","journal-title":"Diabetes Care"},{"issue":"19","key":"570_CR55","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","volume":"358","author":"JA Rowan","year":"2008","unstructured":"Rowan JA et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008;358(19):2003\u201315.","journal-title":"N Engl J Med"},{"issue":"12","key":"570_CR56","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncpendmet0969","volume":"4","author":"DS Feig","year":"2008","unstructured":"Feig DS. Metformin therapy for gestational diabetes mellitus: are we there yet? Nat Clin Pract Endocrinol Metab. 2008;4(12):654\u20135.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"1","key":"570_CR57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dc09-1407","volume":"33","author":"JA Rowan","year":"2010","unstructured":"Rowan JA et al. Glycemia and its relationship to outcomes in the metformin in gestational diabetes trial. Diabetes Care. 2010;33(1):9\u201316.","journal-title":"Diabetes Care"},{"key":"570_CR58","doi-asserted-by":"crossref","unstructured":"Rowan JA et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care. 2011;34(10):2279\u201384. This is the most recent paper in a very important series by these authors reporting on the use of metformin in GDM and the long-term outcomes on offspring.","DOI":"10.2337\/dc11-0660"},{"issue":"9","key":"570_CR59","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1464-5491.2011.03361.x","volume":"28","author":"JE Goh","year":"2011","unstructured":"Goh JE, Sadler L, Rowan J. Metformin for gestational diabetes in routine clinical practice. Diabet Med. 2011;28(9):1082\u20137.","journal-title":"Diabet Med"},{"issue":"6","key":"570_CR60","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1055\/s-0032-1326994","volume":"30","author":"MA Hickman","year":"2013","unstructured":"Hickman MA et al. Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. Am J Perinatol. 2013;30(6):483\u201390.","journal-title":"Am J Perinatol"},{"issue":"3","key":"570_CR61","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1464-5491.2007.02053.x","volume":"24","author":"CO Ekpebegh","year":"2007","unstructured":"Ekpebegh CO et al. A 10-year retrospective analysis of pregnancy outcome in pregestational type 2 diabetes: comparison of insulin and oral glucose-lowering agents. Diabet Med. 2007;24(3):253\u20138.","journal-title":"Diabet Med"},{"issue":"2","key":"570_CR62","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1900\/RDS.2008.5.95","volume":"5","author":"K Tertti","year":"2008","unstructured":"Tertti K et al. Comparison of metformin and insulin in the treatment of gestational diabetes: a retrospective, case-control study. Rev Diabet Stud. 2008;5(2):95\u2013101.","journal-title":"Rev Diabet Stud"},{"issue":"2","key":"570_CR63","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejogrb.2011.11.018","volume":"160","author":"P Gandhi","year":"2012","unstructured":"Gandhi P et al. Introduction of metformin for gestational diabetes mellitus in clinical practice: has it had an impact? Eur J Obstet Gynecol Reprod Biol. 2012;160(2):147\u201350.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"570_CR64","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1464-5491.2009.02780.x","volume":"26","author":"J Balani","year":"2009","unstructured":"Balani J et al. Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: a case-control study. Diabet Med. 2009;26(8):798\u2013802.","journal-title":"Diabet Med"},{"issue":"3","key":"570_CR65","first-page":"327","volume":"4","author":"E Mesdaghinia","year":"2013","unstructured":"Mesdaghinia E et al. Comparison of newborn outcomes in women with gestational diabetes mellitus treated with metformin or insulin: a randomised blinded trial. Int J Prev Med. 2013;4(3):327\u201333.","journal-title":"Int J Prev Med"},{"issue":"1","key":"570_CR66","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/AOG.0b013e3181c52132","volume":"115","author":"LE Moore","year":"2010","unstructured":"Moore LE et al. Metformin compared with glyburide in gestational diabetes: a randomized controlled trial. Obstet Gynecol. 2010;115(1):55\u20139.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"570_CR67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijgo.2010.04.028","volume":"111","author":"JC Silva","year":"2010","unstructured":"Silva JC et al. Metformin compared with glyburide for the management of gestational diabetes. Int J Gynecol Obstet. 2010;111(1):37\u201340.","journal-title":"Int J Gynecol Obstet"},{"key":"570_CR68","first-page":"42","volume":"68","author":"A Zarate","year":"2000","unstructured":"Zarate A et al. Effectiveness of acarbose in the control of glucose tolerance worsening in pregnancy. Ginecol Obstet Mex. 2000;68:42\u20135.","journal-title":"Ginecol Obstet Mex"},{"issue":"8","key":"570_CR69","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1471-0528.1998.tb10234.x","volume":"105","author":"LV Wilton","year":"1998","unstructured":"Wilton LV et al. The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England. Br J Obstet Gynaecol. 1998;105(8):882\u20139.","journal-title":"Br J Obstet Gynaecol"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-014-0570-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-014-0570-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-014-0570-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T20:35:49Z","timestamp":1717706149000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-014-0570-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,27]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["570"],"URL":"https:\/\/doi.org\/10.1007\/s11892-014-0570-5","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,27]]},"article-number":"4"}}